Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (“Fulgen
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
09:46am, Thursday, 22'nd May 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). Such inves
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
09:00am, Wednesday, 21'st May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ:FLGT). Such investors a
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
06:06pm, Tuesday, 20'th May 2025
NEW YORK , May 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT). Such investors are advised
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc
08:11am, Monday, 19'th May 2025
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK , May 19, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder righ
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc
08:48am, Friday, 16'th May 2025
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript
12:27pm, Friday, 02'nd May 2025
Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript
Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates
09:10am, Friday, 02'nd May 2025
Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.19 per share. This compares to loss of $0.01 per share a year ag
Fulgent Reports First Quarter 2025 Financial Results
07:00am, Friday, 02'nd May 2025
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a th
Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025
04:05pm, Thursday, 10'th Apr 2025
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a the
Stock Picks From Seeking Alpha's March 2025 New Analysts
02:30pm, Friday, 04'th Apr 2025
In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and investment strategies. Our analysts covered a diverse set of industries—including
Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy
05:46am, Thursday, 20'th Mar 2025
CFO bought 1.5 million worth on March 5th, a Price/Book ratio of 0.43x and a Net Current Assets Value (NCAV) of 0.68x that day. Now it's trading at 0.47x Price/Book Value and 0.72x NCAV, showing a sig
Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript
11:57am, Friday, 28'th Feb 2025
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Melanie Solomon - IR Ming Hsieh - Chairman and CEO Brandon Perthuis - Chief Com
Fulgent Genetics Revenue Tops Estimates
10:44am, Friday, 28'th Feb 2025
Laboratory services and therapeutic development specialist Fulgent Genetics (FLGT 0.53%) delivered a standout performance in the fourth quarter, topping analysts' consensus estimates. On Friday, Feb.
Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates
09:10am, Friday, 28'th Feb 2025
Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $0.28 per share a yea
